1. Home
  2. GLPG vs GTY Comparison

GLPG vs GTY Comparison

Compare GLPG & GTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Galapagos NV

GLPG

Galapagos NV

HOLD

Current Price

$29.39

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Logo Getty Realty Corporation

GTY

Getty Realty Corporation

HOLD

Current Price

$34.28

Market Cap

1.6B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
GLPG
GTY
Founded
1999
1955
Country
Belgium
United States
Employees
704
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.6B
IPO Year
N/A
1998

Fundamental Metrics

Financial Performance
Metric
GLPG
GTY
Price
$29.39
$34.28
Analyst Decision
Buy
Buy
Analyst Count
2
5
Target Price
$36.50
$32.20
AVG Volume (30 Days)
198.6K
363.6K
Earning Date
05-06-2026
04-22-2026
Dividend Yield
N/A
5.61%
EPS Growth
N/A
8.00
EPS
N/A
1.35
Revenue
N/A
$221,727,000.00
Revenue This Year
N/A
$9.39
Revenue Next Year
N/A
$7.83
P/E Ratio
N/A
$25.64
Revenue Growth
N/A
9.02
52 Week Low
$24.59
$25.39
52 Week High
$37.78
$34.72

Technical Indicators

Market Signals
Indicator
GLPG
GTY
Relative Strength Index (RSI) 42.14 62.79
Support Level $28.78 $26.74
Resistance Level $34.04 N/A
Average True Range (ATR) 0.64 0.57
MACD 0.15 0.14
Stochastic Oscillator 52.52 81.14

Price Performance

Historical Comparison
GLPG
GTY

About GLPG Galapagos NV

Galapagos NV is a fully integrated biotechnology company with operations in Europe and the United States, dedicated to developing medicines focusing on oncology and immunology. The group focuses on unmet medical needs, it synergizes compelling science, technology, and collaborative approaches to create a deep pipeline of medicines. Its clinical pipeline includes: GLPG5101, a CD19 CAR-T product candidate decentralized manufactured, currently in Phase 1/2 in rrNHL; GLPG5301, a BCMA CAR-T product candidate decentralized manufactured, currently in Phase 1 in rrMM; and GLPG3667, a TYK2 inhibitor currently in Phase 2 clinical trial in DM and SLE. It derives maximum revenue from the United States of America.

About GTY Getty Realty Corporation

Getty Realty Corp is the real estate investment trust in the U.S. specializing in the acquisition, financing, and development of convenience, automotive, and other single tenant retail real estate. The company's portfolio includes convenience stores, car washes, automotive service centers (gasoline and repair, oil and maintenance, tire and battery, collision), automotive parts retailers, and certain other freestanding retail properties, including drive-thru quick service restaurants. It generates majority of the revenue in the form of rental income.

Share on Social Networks: